GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspecs Group PLC (LSE:SPEC) » Definitions » EPS (Diluted)

Inspecs Group (LSE:SPEC) EPS (Diluted) : £-0.01 (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Inspecs Group EPS (Diluted)?

Inspecs Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was £-0.03. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

Inspecs Group's EPS (Basic) for the six months ended in Dec. 2023 was £-0.03. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

Inspecs Group's EPS without NRI for the six months ended in Dec. 2023 was £7.53. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was £7.59.

During the past 12 months, Inspecs Group's average EPS without NRIGrowth Rate was 24.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Inspecs Group's highest 3-Year average EPS without NRI Growth Rate was 1089.10% per year. The lowest was -23.10% per year. And the median was 21.60% per year.


Inspecs Group EPS (Diluted) Historical Data

The historical data trend for Inspecs Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspecs Group EPS (Diluted) Chart

Inspecs Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial 13.52 -0.10 -0.04 -0.06 -0.01

Inspecs Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.03 -0.03 0.02 -0.03

Competitive Comparison of Inspecs Group's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Inspecs Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspecs Group's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Inspecs Group's PE Ratio falls into.



Inspecs Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Inspecs Group's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.997-0)/107.246
=-0.01

Inspecs Group's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.08-0)/107.000
=-0.03

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspecs Group  (LSE:SPEC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Inspecs Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Inspecs Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspecs Group (LSE:SPEC) Business Description

Traded in Other Exchanges
N/A
Address
Upper Bristol Road, 7-10 Kelso Place, Bath, Somerset, GBR, BA1 3AU
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. Its customers include optical and Non-optical retailers, global distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Savile Row, Farah, and Nascar among others.